Anaptysbio (ANAB) Other Working Capital Changes (2016 - 2026)
Anaptysbio's (ANAB) quarterly Other Working Capital Changes came in at -$499000.0 in Q1 2026, down 8.01% YoY from -$542442.4 in Q1 2025, and down 1.01% on a QoQ basis from -$494000.0 in Q4 2025.
Anaptysbio (ANAB) Other Working Capital Changes (2016 - 2026) Analysis & Trends
Anaptysbio (ANAB) has 7 years of Other Working Capital Changes data on file, last reported at -$499000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 8.01% year-over-year to -$499000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.0 million (down 8.22% YoY) and the FY2025 annual result came in at -$1.9 million, down 8.33% from the prior year.
- Other Working Capital Changes retreated to -$499000.0 in Q1 2026, from -$494000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $5.8 million in Q3 2023 to a low of -$3.1 million in Q2 2024.
- A 5-year average of -$77000.0 and a median of -$414000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes sank 2045.0% — and 2023, when it declined 7.97%.
- Tracing ANAB's Other Working Capital Changes over 5 years: stood at -$389000.0 in 2022, then retreated by 7.97% to -$420000.0 in 2023, then declined by 8.81% to -$457000.0 in 2024, then fell by 8.1% to -$494000.0 in 2025, then decreased by 1.01% to -$499000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$499000.0 (Q1 2026), -$494000.0 (Q4 2025), and -$490000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Anaptysbio | 1.70 Bn | 1.41 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.50 Mn |
| Mar 31, 2026 | -1.50 Mn |
| Mar 31, 2026 | -1.50 Mn |
| Dec 31, 2025 | -971,000.00 |
| Dec 31, 2025 | -971,000.00 |
| Dec 31, 2025 | -971,000.00 |
| Sep 30, 2025 | 303,000.00 |
| Sep 30, 2025 | 303,000.00 |
| Sep 30, 2025 | 303,000.00 |
| Jun 30, 2025 | -414,000.00 |
| Jun 30, 2025 | -414,000.00 |
| Jun 30, 2025 | -414,000.00 |
| Mar 31, 2025 | -530,000.00 |
| Mar 31, 2025 | -530,000.00 |
| Mar 31, 2025 | -530,000.00 |
| Dec 31, 2024 | -299,000.00 |
| Dec 31, 2024 | -299,000.00 |
| Dec 31, 2024 | -299,000.00 |
| Sep 30, 2024 | -1.41 Mn |
| Sep 30, 2024 | -1.41 Mn |